RecruitingNot ApplicableNCT05900271

Dutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS

Higher, Faster, Better: Is an Accelerated Intermittent Theta Burst Stimulation Protocol Compared to Standard 10 Hz Repetitive Transcranial Magnetic Stimulation, More (Cost-) Effective in Patients With Treatment-resistant Depression?


Sponsor

Amsterdam UMC, location VUmc

Enrollment

108 participants

Start Date

Nov 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

INTRODUCTION Recent findings from three small studies (total n=59) suggest that three changes in repetitive Transcranial Magnetic Stimulation (rTMS) protocols, called the Stanford Neuromodulation Therapy (SNT) protocol, contribute to extreme high overall remission of 79% in patients with treatment resistant depression (TRD), whereas remission using a standard 10 Hz rTMS protocol is 25%. The improvement using the SNT protocol is achieved by combining 1) accelerated treatment with multiple sessions per day, 2) applying a higher overall pulse dose of stimulation, using intermittent Theta Burst Stimulation (iTBS), and 3) precise targeting of the region in the left dorsolateral prefrontal cortex (DLPFC), using functional MRI guided neuronavigation. OBJECTIVE To determine if the SNT protocol is more (cost-) effective compared to standard 10 Hz rTMS in patients with TRD, even though the number of pulses given in both protocols is equal, i.e., 90,000. STUDY DESIGN Multicenter randomized controlled trial comparing SNT with standard 10Hz rTMS with a follow-up of 25 weeks. STUDY POPULATION 108 Patients with TRD (no response to 2 or more evidence-based treatments). INTERVENTION 50 sessions using the SNT protocol in 5 days. The region of the left DLPFC most anticorrelated with the subgenual anterior cingulate cortex in each participant will be targeted based on subject-specific functional resting state MRI. COMPARISON 30 standard daily 10 Hz rTMS sessions in six weeks, targeting the left DLPFC based on standard measurement procedures of the skull. OUTCOME MEASURES * Remission, based on the Hamilton depression rating scale * Cost effectiveness, based on healthcare resource use * Quality of life and positive mental health * Tolerability and safety * Relapse * Description of opportunities and difficulties with regard to implementation SAMPLE SIZE The investigators will enrol 108 patients (α=0.05, power is 0.80) including adjustment for attrition. COST EFFECTIVENESS ANALYSIS SNT is faster and possibly more effective than 10Hz rTMS leading to a total cost reduction of 22 million each year considering less expensive healthcare, reduced illness duration and absence from work. TIME SCHEDULE Within 36 months, the investigators will recruit and treat 108 patients with TRD: each center will recruit 9 patients per year. After the last follow-up assessments, the investigators will finalise the study within 12 months and report the results.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two types of brain stimulation for treatment-resistant depression: a standard 6-week course of repetitive TMS (transcranial magnetic stimulation) versus an intensive 5-day version using a more targeted technique called theta burst stimulation. **You may be eligible if...** - You are 18 or older and speak Dutch - You have a current diagnosis of a depressive episode, confirmed by a psychiatric interview - You scored above 16 on a depression rating scale - Your depression is treatment-resistant — meaning two different antidepressants taken at adequate doses for at least 8 weeks each did not bring you into remission - Your medications have been stable for at least 6 weeks **You may NOT be eligible if...** - You have bipolar disorder - You are currently experiencing psychosis - You have a history of seizures or epilepsy - You have a metal implant in or near your head (e.g., cochlear implant, deep brain stimulator) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICErTMS

10 Hz repetitive-transcranial-magnetic-stimulation

DEVICEiTBS

neuronavigated intermittent theta burst transcranial-magnetic-stimulation


Locations(4)

Radboud UMC

Nijmegen, GL, Netherlands

GGZinGeest

Amsterdam, North Holland, Netherlands

Amsterdam UMC location AMC

Amsterdam-Zuidoost, North Holland, Netherlands

Maastricht UMC

Maastricht, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05900271


Related Trials